Unlock the Power of DNA

Picture of Amped Universal qPCR Reagent

At Amped PCR, we empower life science researchers and scientists with our high-performance diagnostic technologies.

We specialise in advanced Polymerase Chain Reaction (PCR) technology, providing robust diagnostic tools tailored to the life sciences and for critical sectors such as food safety, environmental monitoring and veterinary diagnostics.

We are addressing global safety challenges by delivering rapid, accurate and cost-effective pathogen detection solutions.

Backed by DBW & SFC Capital, our flagship innovation, PurifAI, is a deployable pathogen detection lab system that delivers results in under four hours. This transformative solution helps organisations efficiently mitigate pathogen-related risks.

By collaborating with industry leaders who share our commitment, we aim to reduce risks, protect public health and enhance global biosurveillance efforts.

Together, we are driving advancements in PCR-based and genomic diagnostics to help safeguard public health worldwide.

Management Team

Founded by Ben Davis and Aysha Shah.

Ben Davis, Founder of Amped PCR and PurifAI Inventor


  • Founder & CEO

    Founder Ben Davis leads Amped PCR with over 15 years of experience driving innovation in the biotech industry.

    His proven ability to secure strategic partnerships and scale solutions from concept to commercialisation was critical to securing pre-seed investment for Amped PCR from the Development Bank of Wales (DBW) and SFC Capital, the UK’s leading SEIS/EIS fund managers.

    Ben's leadership has fostered collaborations with industry giants in Manufacturing, resulting in advancements across reagent design, cleanroom workflows, and data analytics.

    His prior experience at NuGEN Technologies, The Technology Partnership (TTP, and LGC Genomics includes leading multi-million-pound projects, developing rapid PCR formulations and co-developing PuckDX—a point-of-care qPCR platform now licensed to Diasorin.

    Ben's innovative approach combines technical expertise with sharp business acumen.

Aysha Shah, Co-Founder of Amped PCR and Designer


  • Co-Founder & Director

    Co-Founder of Amped PCR, Aysha brings a unique blend of design innovation and strategic communication expertise to the company's leadership.

    A graduate of The Cass School of Art, Architecture & Design, her award-winning product design background includes collaborations with prestigious brands like Heal's and recognition in the Financial Times.

    As a cornerstone of Amped PCR's success, Aysha leads the company's design philosophy, ensuring products combine cutting-edge functionality with intuitive user experience.

    Her strategic approach to communication has been instrumental in articulating the company's vision, contributing to successful funding rounds with DBW and SFC Capital.

    In comms, her work regularly featured in BBC News and other national media outlets.

    With a keen focus on user-centered design and stakeholder engagement, Aysha drives Amped PCR's mission to make advanced PCR technologies accessible and user-friendly.

    Her multifaceted expertise in design, communication, and investor relations continues to shape the company's growth and market position in the biotechnology sector.


Get in touch.

If you have questions or want to learn more about our products and services, we are here to assist with any enquiries.